Formulation and Evaluation of Acyclovir Loaded Transferosomal Gel for Transdermal Drug Delivery
Abstract
Background: A carrying structure for targeted transdermal drug delivery is a transferosome. These unique liposomes are made of an edge activator and phosphatidylcholine. The most common antiviral drug is acyclovir, a synthetic nucleotide nucleoside analog derived from guanine. It works well to cure the varicella-zoster virus and the virus that causes herpes simplex (HSV), primarily HSV-1 and HSV-2. But its skin permeability is minimal. Therefore, this work aimed to use transferosomes to prepare acyclovir so that it could pass through the skin's barrier function.
Objective: This study uses a 32-factorial factorial design to develop a transferosomal gel containing acyclovir through thin-film hydration method for painless acyclovir delivery services for skin disease treatment.
Material and Methods: The independent variables are the amount of phospholipid (X1) and tween 80 (X2), while the dependent variables are particle size (Y1) and percentage entrapment efficiency (Y2). To create an ideal formulation, the produced transferosomes were assessed for particle size, in vitro drug release amount, and entrapment efficiency (EE%). A Carbopol 934 gel basis was prepared using the optimized acyclovir transferosome formulation, and its drug concentration, pH, spreadability, viscosity, and stability were assessed.
Results: With small particles ranging from 176.6 to 324.4 nm, the produced acyclovir transferosomes had a high EE% range from 66.34 to 76.42 %. According to the in vitro release study, there is a negative correlation between in vitro release and EE%. The formulation TF5, including 1%w/w of carbopol 940, provides a superior profile of drug absorption in vitro. Consequently, acyclovir can enter the skin as transferosomes and cross the stratum corneum barrier.
Conclusion: Acyclovir can be transformed into a transfersomal gel, which will improve antiviral efficacy, get over the skin's protective layer, prevent adverse oral reactions, and eventually improve patient adherence.
Keywords: Transferosome, Transdermal drug delivery system, Acyclovir, 32 Fractional factorial design, Carbopol 934
Keywords:
Transferosome, Transdermal drug delivery system, Transferosome gel, Acyclovir, 32 Fractional factorial designs, Carbopol 934DOI
https://doi.org/10.22270/jddt.v14i9.6786References
Kumavat SD, Chaudhari YS, Borole P, Duvvuri P, Bubera N, Shenghani K et.al. Transfersomes: A Promising approach for transdermal drug delivery system.Asian Journal of Pharmaceutical Scienceand Research.2013;3(5):1-17.
Darajat NZ, Chaerunisa A, Abdassah M. Transfersome as Topical Drug Delivery: Formulation and Characterization. Journal Farmasi Galenika. 2023;9(1):41-54. https://doi.org/10.22487/j24428744..v.i.16030
Kumar A, Nayak A, Ghatuary S. Design, Optimization and Characterization of a Transferosomal Gel of Acyclovir for Effective Treatment of Herpes Zoster. Journal of Drug Delivery & Therapeutics. 2019;9(4-A):712-721. https://doi.org/10.22270/jddt.v9i4-A.3556
Chaurasiya P, Ganju E, Upmanyu N, Ray SK, Jain P. Transfersomes a novel technique for transdermal drug delivery. Journal of Drug Delivery & Therapeutics.2019;9(1):279-285. https://doi.org/10.22270/jddt.v9i1.2198
Tiwari A, Parashar M, Banweer J. Formulation and Evaluation of Acyclovir Invasome Gel for Treatment of Topical Disease. World Journal of Pharmacy and Pharmaceutical Sciences.2022;11(8):1517-1526.
Khan MY, & Kumar R. Acyclovir: An overview. Pharmacology & Pharmacy. 2010;1(2):146-159.
Ali H, & Hwang KM. Recent advances in the formulation and delivery of acyclovir for the treatment of viral infections. Pharmaceutical Research. 2021;38(9):1533-1548.
Khan MY, Kumar S, Pandey V. Nanoparticle-based delivery systems for acyclovir: A review. Journal of Nanoscience and Nanotechnology. 2018;18(5):3039-3054.
Wang Y, Lee HK, Liu X. Acyclovir-loaded liposomes and their in vivo efficacy in herpes simplex virus infection. European Journal of Pharmaceutics and Biopharmaceutics. 2022;171:178-186.
Yao H, & Zhang X. Enhancement of acyclovir solubility and bioavailability through solid dispersion techniques. International Journal of Pharmaceutics. 2019;572(1-2):146-156.
Sanghavi NM, & Mody VV. Development and evaluation of acyclovir nanosuspensions for improved oral bioavailability. Journal of Drug Delivery Science and Technology. 2020;57:101-109.
Hussain A, Altamimi MA, Afzal O, Altamimi ASA, Ramzan M, Khuroo T. Mechanistic of Vesicular Ethosomes and Elastic Liposomes on Permeation Profiles of Acyclovir across Artificial Membrane, Human Cultured EpiDerm, and Rat Skin: In Vitro-Ex Vivo Study. Pharmaceutics. 2023;15(9):2189. https://doi.org/10.3390/pharmaceutics15092189 PMid:37765159 PMCid:PMC10534565
Shukla K V., Meshram R., Yadav M. Formulation, Development and Evaluation of Transferosomal Gel of Metronidazole. Journal of Drug Delivery & Therapeutics. 2019; 9(4-A):642-645. https://doi.org/10.22270/jddt.v9i4-A.3544
Mulla JAS, Shetty NS, Panchamukhi SI,Khazi IAM. Formulation, Characterization and in vitro Evaluation of Novel Thienopyrimidines and Triazolothienopyrimidines Loaded Solid Lipid Nanoparticles. International Journal of Research in Ayurveda & Pharmacy. 2010; 1(1): 192-200.
Mulla JS, KhaziIM. Influence of Process Variables on Particle Size of Solid Lipid Nanoparticles. Indian Journal of Novel Drug Delivery, 2009; 1(1):47-49.
Mulla JA, Khazi MI, Khan AY, Gong YD, Khazi IA. Design, Characterization and In vitro Evaluation of Imidazo [2, 1-b][1, 3, 4] thiadiazole Derivative Loaded Solid Lipid Nanoparticles. Drug Invention Today. 2012 Aug 1;4(8).
Panchamukhi SI, Mulla JA, Shetty NS, Khazi MI, Khan AY, Kalashetti MB, Khazi IA. Benzothieno [3, 2‐e][1, 2, 4] triazolo [4, 3‐c] pyrimidines: Synthesis, Characterization, Antimicrobial Activity, and Incorporation into Solid Lipid Nanoparticles. Archiv der Pharmazie. 2011 Jun;344(6):358-65. https://doi.org/10.1002/ardp.201000227 PMid:21456079
Begum A, Basha SA, Mohammed S, Begum A. Formulation Development and In-vitro Evaluation of Transferosomal Gel of MometasoneFuroate. Journal of Drug Delivery & Therapeutics. 2023;13(12):91-102. https://doi.org/10.22270/jddt.v13i12.6101
Mulla JA, Suresh S, Khazi IA. Formulation, characterization and in vitro evaluation of methotrexate solid lipid nanoparticles. Research J. Pharm. and Tech. 2009 Oct;2(4):685-9.
Mulla JS, Khazi IM, Sharma NK. Solid Lipid Nanoparticles: Measures of Characterization. Indian Journal of Novel Drug delivery. 2011; 3(4): 259-264.
Mulla JAS, Aralelimath VR, Tipugade O, Shinde SS, Tetgure NG, Mulla AA, Gavali DD. Formulation and Evaluation of Teneligliptin-Loaded Mucoadhesive Microspheres. Indian Journal of Novel Drug Delivery. 2020Oct-Dec;12(4): 222-227.
Mulla JA, Mabrouk M, Choonara YE, Kumar P, Chejara DR, du Toit LC, Pillay V. Development of respirable rifampicin-loaded nano-lipomer composites by microemulsion-spray drying for pulmonary delivery. Journal of Drug Delivery Science and Technology. 2017 Oct 1;41:13-19. https://doi.org/10.1016/j.jddst.2017.06.017
Thakur N, Jain P, Jain V. Formulation Development and Evaluation of Transferosomal Gel. Journal of Drug Delivery & Therapeutics. 2018;8(5):168-177. https://doi.org/10.22270/jddt.v8i5.1826
Shamma R N and Elsayed I. Transfersomal lyophilized gel of buspironeHCl: formulation, evaluation and statistical optimization. Journal of Liposome Research. 2013;23(3):244-254. https://doi.org/10.3109/08982104.2013.801489 PMid:23713516
Yameen SY, Shahidulla SM. Formulation and evaluation of Lamivudine transferosomal gel. Journal of Drug Delivery & Therapeutics. 2022; 12(4-s):163-170. https://doi.org/10.22270/jddt.v12i4-S.5768
Parveen S & Mittapally S. Formulation and In-vitro evaluation of topical transferosomal gel of bifonazole for fungal infections. The Pharma Innovation Journal 2018;7(7):711-720.
Fatima H & Shahidulla S M. Formulation, Optimization and Evaluation of Glimepiride Transferosomal Gel for Antidiabetic Activity in Rats. International Journal of Pharmaceutical Sciences and Research. 2022;13(10):3983-3999.
Ali SS, Gudipati M, Nadendla R. Development and characterization of miconazole nitrate transferosomal gel. International Journal of Research in Pharmaceutical sciences and Technology. 2020;1(4):109-116. https://doi.org/10.33974/ijrpst.v1i4.200
Dhore SM, Waghmare SA, Kamble HV. A Review on Preformulation Studies. International Journal of All Research Education and Scientific Methods. 2022;10(3):834-843.
Mabrouk M, Mulla JA, Kumar P, Chejara DR, Badhe RV, Choonara YE, du Toit LC, Pillay V. Intestinal targeting of ganciclovir release employing a novel HEC-PAA blended lyomatrix. AAPS PharmScitech. 2016 Oct;17(5):1120-30. https://doi.org/10.1208/s12249-015-0442-6 PMid:26552400
Mulla JA, Hiremath SP, Sharma NK. Repaglinide loaded solid lipid nanoparticles: design and characterization. RGUHS J Pharm Sci. 2012 Oct;2(4):41-9.
Published
Abstract Display: 452 
PDF Downloads: 193 PDF Downloads: 71 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.